首页 > 市场调查报告书 > 製药

自体免疫疾病

市场调查报告书

商品编码

1820236

2025 年至 2033 年免疫调节剂市场报告（按产品（免疫抑制剂、免疫刺激剂）、应用（肿瘤学、呼吸系统疾病、爱滋病毒等）和地区划分）

Immunomodulators Market Report by Product (Immunosuppressants, Immunostimulants), Application (Oncology, Respiratory, HIV, and Others), and Region 2025-2033

出版日期: 2025年09月01日 | 出版商:

IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2024 年全球免疫调节剂市场规模达 2,217 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 3,391 亿美元，2025-2033 年期间的成长率 (CAGR) 为 4.8%。

免疫调节剂是一类用于调节免疫反应以对抗传染病、免疫缺陷和抗体转移改变的药物。这类药物通常包括单株抗体、细胞激素、左旋咪唑和卡介苗 (BCG)。它们被广泛用于治疗癌症、气喘、肿瘤、遗传性血管性水肿以及天疱疮、狼疮、过敏和类风湿性关节炎等自体免疫疾病。如今，一些医疗保健提供者建议将免疫调节剂与其他药物（例如生物製剂）联合用于治疗发炎性肠道疾病 (IBD)。

免疫调节剂市场趋势：

快速城市化、收入水平膨胀以及加工食品消费的增加导致人们的生活方式不健康，导致全球慢性病盛行率显着上升。这进一步增加了器官移植的需求，从而对局部免疫调节剂的需求产生了积极影响，因为局部免疫调节剂是器官移植接受者的一种有前景的治疗药物。此外，老化人口的增加和事故数量的增加也增加了器官衰竭的风险。因此，一些政府和非政府机构都在鼓励器官捐赠，这反过来又推动了全球局部免疫调节剂的销售。此外，发炎性肠道疾病 (IBD) 和自体免疫疾病的盛行率不断上升也促进了市场的成长。免疫调节剂也用于合併治疗，以减少对类固醇的长期需求，预防復发性发作，并治疗对抗生素无效的疾病。此外，包括氟伏沙明、托珠单抗以及巴瑞替尼和瑞德西韦在内的多种免疫调节剂正在用于治疗新冠肺炎住院患者。此外，目前还有几种候选产品处于后期临床试验阶段。这些产品的开发预计将扩大免疫调节剂在治疗各种危及生命的疾病的应用。

本报告回答的关键问题：

全球免疫调节剂市场迄今表现如何？未来几年将如何表现？
COVID-19 对全球免疫调节剂市场有何影响？
主要的区域市场有哪些？
根据产品，市场是如何分類的？
根据应用，市场是如何分類的？
该产业的价值链分为哪些阶段？
该行业的主要驱动因素和挑战是什么？
全球免疫调节剂市场的结构是怎么样的？主要参与者是谁？
产业竞争程度如何？

Immunomodulators are a group of drugs used to modify an immune response against infectious diseases, immunodeficiency, and alterations in antibody transfer. These drugs generally include monoclonal antibodies, cytokines, levamisole, and Bacillus Calmette-Guerin (BCG). They are widely used to treat cancer, asthma, tumors, hereditary angioedema, and autoimmune disorders like pemphigus, lupus, allergies, and rheumatoid arthritis. Nowadays, several healthcare providers are recommending immunomodulators with other agents, such as biologics, for managing inflammatory bowel disease (IBD).

Immunomodulators Market Trends:

The unhealthy lifestyles of individuals on account of rapid urbanization, inflating income levels, and the increasing consumption of processed food products has led to a significant rise in the prevalence of chronic diseases worldwide. This is further escalating the need for organ transplantation, which is positively influencing the demand for topical immunomodulators as a promising therapeutic agent in organ transplant recipients. Moreover, the rising aging population and the growing number of accidents are also increasing the risk of organ failure. Consequently, several governing and non-governing authorities are encouraging organ donation, which, in turn, is boosting the sales of topical immunomodulators worldwide. Apart from this, the increasing prevalence of IBD and autoimmune disorders is bolstering the market growth. Immunomodulators are also utilized in combination therapy to decrease the long-term need for steroids and prevent recurring flares and treat diseases that do not respond to antibiotics. Furthermore, several immunomodulators, including Fluvoxamine, Tocilizumab, and Baricitinib with Remdesivir, are finding application for treating hospitalized patients with coronavirus disease (COVID-19). Besides this, several product candidates are currently in late-stage clinical trials. The development of these products is anticipated to expand the applications of immunomodulators for treating various life-threatening diseases.

Key Market Segmentation:

Breakup by Product:

Immunosuppressants
- Antibodies
- Calcineurin Inhibitors
- Glucocorticoids
- Antimetabolites
- Others
Immunostimulants
- Vaccines
- Antibodies
- Others

Breakup by Application:

Oncology
Respiratory
HIV
Others

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG and Pfizer Inc.

Key Questions Answered in This Report:

How has the global immunomodulators market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global immunomodulators market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global immunomodulators market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Immunomodulators Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Immunosuppressants
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Antibodies
  - 6.1.2.2 Calcineurin Inhibitors
  - 6.1.2.3 Glucocorticoids
  - 6.1.2.4 Antimetabolites
  - 6.1.2.5 Others
- 6.1.3 Market Forecast
6.2 Immunostimulants
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Vaccines
  - 6.2.2.2 Antibodies
  - 6.2.2.3 Others
- 6.2.3 Market Forecast

7 Market Breakup by Application

7.1 Oncology
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Respiratory
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 HIV
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 SWOT Analysis

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Amgen Inc.
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 Biogen Inc.
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
  - 13.3.2.3 Financials
  - 13.3.2.4 SWOT Analysis
- 13.3.3 Bristol-Myers Squibb Company
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
  - 13.3.3.3 Financials
  - 13.3.3.4 SWOT Analysis
- 13.3.4 Eli Lilly and Company
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
  - 13.3.4.4 SWOT Analysis
- 13.3.5 F. Hoffmann-La Roche AG
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
  - 13.3.5.3 SWOT Analysis
- 13.3.6 Johnson & Johnson
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
  - 13.3.6.3 Financials
  - 13.3.6.4 SWOT Analysis
- 13.3.7 Merck & Co. Inc.
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
  - 13.3.7.3 Financials
  - 13.3.7.4 SWOT Analysis
- 13.3.8 Novartis AG
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
  - 13.3.8.3 Financials
  - 13.3.8.4 SWOT Analysis
- 13.3.9 Pfizer Inc.
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio
  - 13.3.9.3 Financials
  - 13.3.9.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Immunomodulators Market: Major Drivers and Challenges
Figure 2: Global: Immunomodulators Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Immunomodulators Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Immunomodulators Market: Breakup by Product (in %), 2024
Figure 5: Global: Immunomodulators Market: Breakup by Application (in %), 2024
Figure 6: Global: Immunomodulators Market: Breakup by Region (in %), 2024
Figure 7: Global: Immunomodulators (Immunosuppressants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Immunomodulators (Immunosuppressants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Immunomodulators (Immunostimulants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Immunomodulators (Immunostimulants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Immunomodulators (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Immunomodulators (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Immunomodulators (Respiratory) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Immunomodulators (Respiratory) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Immunomodulators (HIV) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Immunomodulators (HIV) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Immunomodulators (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Immunomodulators (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: North America: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: North America: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: United States: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: United States: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Canada: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Canada: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Asia-Pacific: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Asia-Pacific: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: China: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: China: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Japan: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Japan: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: India: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: India: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: South Korea: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: South Korea: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Australia: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Australia: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Indonesia: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Indonesia: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Others: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Others: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Europe: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Europe: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Germany: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Germany: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: France: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: France: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: United Kingdom: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: United Kingdom: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Italy: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Italy: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Spain: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Spain: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Russia: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Russia: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Others: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Others: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Latin America: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Latin America: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Brazil: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Brazil: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Mexico: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Mexico: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Others: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Others: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Middle East and Africa: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Middle East and Africa: Immunomodulators Market: Breakup by Country (in %), 2024
Figure 67: Middle East and Africa: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Global: Immunomodulators Industry: SWOT Analysis
Figure 69: Global: Immunomodulators Industry: Value Chain Analysis
Figure 70: Global: Immunomodulators Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Immunomodulators Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Immunomodulators Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Immunomodulators Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Immunomodulators Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Immunomodulators Market: Competitive Structure
Table 6: Global: Immunomodulators Market: Key Players

02-2729-4219

+886-2-2729-4219

License/价格

2025 年至 2033 年免疫调节剂市场报告（按产品（免疫抑制剂、免疫刺激剂）、应用（肿瘤学、呼吸系统疾病、爱滋病毒等）和地区划分）

Immunomodulators Market Report by Product (Immunosuppressants, Immunostimulants), Application (Oncology, Respiratory, HIV, and Others), and Region 2025-2033

免疫调节剂市场趋势：

本报告回答的关键问题：

目录

第一章：前言

第二章：范围与方法

第三章：执行摘要

第四章：简介

第五章：全球免疫调节剂市场

第六章：市场区隔：依产品

第七章：市场区隔：依应用

第八章：市场区隔：依地区

第九章：SWOT分析

第 10 章：价值链分析

第 11 章：波特五力分析

第 12 章：价格分析

第 13 章：竞争格局